IRIDEX Corporation (IRIX)
0.99
0.11 (12.12%)
At close: Mar 28, 2025, 3:57 PM
0.99
0.00%
After-hours: Mar 28, 2025, 05:58 PM EDT
12.12% (1D)
| Bid | 0.95 |
| Market Cap | 16.41M |
| Revenue (ttm) | 48.59M |
| Net Income (ttm) | -11.07M |
| EPS (ttm) | -0.67 |
| PE Ratio (ttm) | -1.47 |
| Forward PE | -6.15 |
| Analyst | Hold |
| Ask | 1.13 |
| Volume | 445,822 |
| Avg. Volume (20D) | 63,668 |
| Open | 1.06 |
| Previous Close | 0.88 |
| Day's Range | 0.91 - 1.07 |
| 52-Week Range | 0.78 - 3.65 |
| Beta | 0.94 |
About IRIX
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuL...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 16, 1996
Employees 111
Stock Exchange NASDAQ
Ticker Symbol IRIX
Website https://www.iridex.com
Analyst Forecast
According to 1 analyst ratings, the average rating for IRIX stock is "Hold." The 12-month stock price forecast is $2, which is an increase of 102.82% from the latest price.
Stock Forecasts1 day ago
Iridex shares are trading higher after the company...
Unlock content with
Pro Subscription
4 months ago
+34.04%
IRIDEX shares are trading higher. The company reported Q3 financial results.
